Peter P. Lee
City Of Hope National Medical Center · 446 works · 15,214 citations · h-index 64
Top works
- Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients
- Autoimmunity in a Phase I Trial of a Fully Human Anti-Cytotoxic T-Lymphocyte Antigen-4 Monoclonal Antibody With Multiple Melanoma Peptides and Montanide ISA 51 for Patients With Resected Stages III and IV Melanoma
- Evidence that specific T lymphocytes may participate in the elimination of chronic myelogenous leukemia
- Isolation of High Avidity Melanoma-Reactive CTL from Heterogeneous Populations Using Peptide-MHC Tetramers
- Melanocyte Destruction after Antigen-Specific Immunotherapy of Melanoma
- Ex vivo identification, isolation and analysis of tumor-cytolytic T cells
- Immunologic Monitoring of Cancer Vaccine Therapy: Results of a Workshop Sponsored by the Society for Biological Therapy
- A comparison of two types of dendritic cell as adjuvants for the induction of melanoma-specific T-cell responses in humans following intranodal injection
- Effects of Interleukin-12 on the Immune Response to a Multipeptide Vaccine for Resected Metastatic Melanoma
- Profile of Immune Cells in Axillary Lymph Nodes Predicts Disease-Free Survival in Breast Cancer
- Granulocyte‐macrophage–colony‐stimulating factor added to a multipeptide vaccine for resected Stage II melanoma
- Chronic myelogenous leukemia shapes host immunity by selective deletion of high-avidity leukemia-specific T cells
- A Self-Directed Method for Cell-Type Identification and Separation of Gene Expression Microarrays
- A phase I trial of tumor lysate-pulsed dendritic cells in the treatment of advanced cancer.
- A PR1-human leukocyte antigen-A2 tetramer can be used to isolate low-frequency cytotoxic T lymphocytes from healthy donors that selectively lyse chronic myelogenous leukemia.
- Response to PD-1 Blockade in Microsatellite Stable Metastatic Colorectal Cancer Harboring aPOLEMutation
- Recommendations from the iSBTc-SITC/FDA/NCI Workshop on Immunotherapy Biomarkers
- Impaired interferon signaling is a common immune defect in human cancer
- Marked Differences in Human Melanoma Antigen-Specific T Cell Responsiveness after Vaccination Using a Functional Microarray
- Gene expression network analysis and applications to immunology